Chitosan-PLGA biopolymeric nanogel as a platform for enhanced methotrexate delivery and redox-modulated anti-inflammatory activity
Bioorganic Chemistry · 2026
DOI: 10.1016/j.bioorg.2026.110412 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026. Verfasst von Reem Darwesh und 9 weiteren Autor:innen. Beteiligte Einrichtung: Physics Department, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia. Hauptthemen laut MEDLINE: Methotrexate, Chitosan, Anti-Inflammatory Agents, Drug Carriers. Die Arbeit nennt 83 Literaturangaben. Gefördert von: Taif University, Princess Nourah Bint Abdulrahman University.
Abstract (Originalsprache)
Methotrexate (MTX) is an effective disease-modifying antirheumatic drug for the treatment of chronic inflammatory disorders; however, its clinical application is limited by poor bioavailability, rapid systemic clearance, and dose-dependent adverse effects. In this study, a pH-responsive methotrexate-loaded chitosan/poly(lactic-co-glycolic acid) ((Chit/PLGA)/MTX) nanogel was developed to improve drug delivery and therapeutic performance. The nanogel was fabricated by ionic gelation followed by gamma radiation-induced in situ free-radical polymerization (20 kGy) and subsequently loaded with methotrexate using a pH-triggered swelling-shrinking encapsulation strategy. Physicochemical characterization by TEM, DLS, FTIR, UV-Vis spectroscopy, and zeta potential analysis confirmed the successful formation of spherical nanogel particles with an average hydrodynamic diameter of 125 nm, a polydispersity index of 0.18 ± 0.03, and a zeta potential of -2.5 mV. The nanogel exhibited a high encapsulation efficiency (89.3 ± 2.1%) and drug-loading capacity (15.1 ± 0.8%). In vitro release studies demonstrated pronounced pH-responsive behavior, with cumulative methotrexate release reaching approximately 60% at pH 5.5 compared with 40% at pH 7.4 after 300 s, indicating preferential drug release under acidic inflammatory conditions. Cytotoxicity evaluation showed that the nanogel formulation exhibited improved biocompatibility (IC₅₀ = 422.5 μg/mL) compared with free methotrexate (IC₅₀ = 311.7 μg/mL). The (Chit/PLGA)/MTX nanogel significantly enhanced antioxidant activity, exhibiting 79.1% DPPH radical scavenging, 81.8% membrane stabilization, and 83.3% inhibition of protein denaturation. Furthermore, the formulation effectively suppressed the expression of major inflammatory mediators, including COX-2 (37.2%), iNOS (47.2%), TNF-α (40.3%), and NF-κB (40.9%), while reducing IL-1β (33.5%) and IL-6 (45.0%) production. Collectively, these findings demonstrate that the pH-responsive Chitosan-PLGA nanogel provides efficient methotrexate encapsulation, controlled drug release, enhanced antioxidant activity, and potent anti-inflammatory effects, highlighting its promise as a nanocarrier platform for the treatment of chronic inflammatory diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Physics Department, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia.
- Department of Chemistry, College of Science, Taif University, P.O. Box 11099, Taif, 21944, Saudi Arabia; Research Center of Basic Sciences, Engineering and High Altitude, Taif University, Taif, Saudi Arabia.
- Department of Chemistry, College of Science, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia.
- Radiation Research of Polymer Department, National Center for Radiation Research and Technology (NCRRT), Atomic Energy Authority, P.O. Box 29, Nasr City, Cairo, Egypt. Electronic address: Mohamed_ghobashy@yahoo.com.
- Al-Azhar University, Cairo, Egypt.
- Biochemistry Department, Damietta Faculty of Medicine, Al-Azhar University, Damietta, Egypt.
Förderung
- Taif University
- Princess Nourah Bint Abdulrahman University
Zitieren
APA
Darwesh, R., Alharthi, S., Al-Shaalan, N. H., Ghobashy, M. M., Shaaban, F. M., Hammad, A. M., Zayed, E. M., Hassan, R. E., Alrabghi, G., & Kodous, A. S. (2026). Chitosan-PLGA biopolymeric nanogel as a platform for enhanced methotrexate delivery and redox-modulated anti-inflammatory activity. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2026.110412
Vancouver
Darwesh R, Alharthi S, Al-Shaalan NH, Ghobashy MM, Shaaban FM, Hammad AM, et al. Chitosan-PLGA biopolymeric nanogel as a platform for enhanced methotrexate delivery and redox-modulated anti-inflammatory activity. Bioorganic Chemistry. 2026. doi:10.1016/j.bioorg.2026.110412
BibTeX
@article{Darwesh2026,
author = {Darwesh, Reem and Alharthi, Sarah and Al-Shaalan, Nora Hamad and Ghobashy, Mohamed Mohamady and Shaaban, Fatima M and Hammad, Amal M and Zayed, Ehab M and Hassan, Rasha E and Alrabghi, Ghadah and Kodous, Ahmad S},
title = {Chitosan-PLGA biopolymeric nanogel as a platform for enhanced methotrexate delivery and redox-modulated anti-inflammatory activity},
journal = {Bioorganic Chemistry},
year = {2026},
doi = {10.1016/j.bioorg.2026.110412}
}
EUVIMED